Arko Corp. vs Twist Bioscience Corp — how do they compare? Arko Corp. trades at $4.39 (market cap $493.06M), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 15.7× Arko Corp.'s market cap, and Arko Corp. pays a 2.73% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ARKO | TWST | |
|---|---|---|
Market Cap | $493.06M | $7.72B |
Sector | Consumer Cyclical | Health |
52-Week High | $8.64 | $124.88 |
52-Week Low | $3.82 | $24.16 |
Enterprise Value | $2.67B | $7.65B |
Dividend Yield | 2.73% | — |
Trailing returns across standard periods
Latest headlines on both assets
ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
Read more on ARKO →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →